For Clinicians

As a clinician, you aim to provide the best treatment for all of your patients. When it comes to wound healing, that means an effective regimen that’s safe, affordable, and convenient for patients and their caregivers. EPIFLO integrates portability with the healing benefits of oxygen, allowing patients to experience life while on the mend.

For Clinicians

As a clinician, you aim to provide the best treatment for all of your patients. When it comes to wound healing, that means an effective regimen that’s safe, affordable, and convenient for patients and their caregivers. EPIFLO integrates portability with the healing benefits of oxygen, allowing patients to experience life while on the mend.

Indications for use

EPIFLO has FDA clearance to provide safe and effective Transdermal Continuous Oxygen Therapy (TCOT) for the treatment of:

  • Skin ulcerations due to diabetes, venous stasis, post-surgical infections, and gangrenous lesions
  • Decubitus ulcers (bedsores, pressure sores)

About Transdermal Continuous Oxygen Therapy

Transdermal Continuous Oxygen Therapy (TCOT) provides a steady flow of oxygen to wounds 24 hours a day, seven days a week, until healed. Typically used to treat chronic and acute wounds, TCOT involves placing a thin tube (or “cannula”) above a clean wound bed. An absorbent dressing is placed over the cannula and wound site. The opposite end of the cannula is connected to an oxygen delivery unit which delivers a continuous flow of oxygen at a rate of about 3ml per hour.

Unlike hyperbaric or topical oxygen therapies that can involve 20-40 separate treatments in an outpatient setting, TCOT administers safe, effective treatment 24/7 wherever the patient may be.

Why choose EPIFLO?

An FDA-cleared device, EPIFLO’s compact size and light weight make it easy for you or your loved ones to go about their daily routines without being encumbered by stationary machines or trips to outpatient facilities for expensive treatments. Patients using EPIFLO benefit from:

Convenience (much higher than other therapies)

24/7 wound treatment (continuous)

Lower cost (when compared to alternatives)

Safe and effective approach

Studies suggest patients may also experience improved healing at a faster rate.

Clinical research findings

Studies indicate that “TCOT [transdermal continuous oxygen therapy] provides a cost-effective and portable option for oxygen therapy for chronic wound treatment” and further suggest “that TCOT can increase healing and reduce time to complete closure,” particularly in older patients suffering from conditions like diabetic foot ulcers.

Overview: EPIFLO (TCOT) Study

Trial: TCOT Compared to Moist Wound Therapy

Pilot Study: TCOT for Chronic Wounds

Case studies

CASE STUDY

Diabetic Foot Ulcer + Osteomyelitis

CASE STUDY

Problematic Surgical Wound

CASE STUDY

Venous Leg Ulcer

Get in touch today

We'd love to hear from you.